GASTROESOPHAGEAL CANCER
Clinical trials for GASTROESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to fight advanced cancers
Disease control CompletedThis study tested a new drug called gevokizumab when added to standard cancer treatments. It involved 167 adults with advanced colorectal, gastroesophageal, or kidney cancer that had spread. The main goals were to find a safe and effective dose and to see if the combination could…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Radiation boost tested to help more stomach cancer patients survive surgery
Disease control CompletedThis study tested whether adding radiation therapy to chemotherapy before surgery works better than chemotherapy alone for people with locally advanced stomach cancer. Researchers wanted to see if this combined approach helps patients live longer without their cancer returning. T…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE3 • Sponsor: Shanghai Cancer Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Strong chemo cocktail tested to shrink tough stomach tumors before surgery
Disease control CompletedThis was a small, early-phase study to see if a powerful combination of chemotherapy drugs (called FOLFIRINOX) followed by radiation and more chemo could be safely given before surgery for stomach and GE junction cancer. The goal was to shrink tumors and control the disease to im…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Breakthrough combo therapy shows promise against deadly stomach cancers
Disease control CompletedThis large study tested whether adding two newer drugs (camrelizumab and apatinib) to standard chemotherapy works better than chemotherapy alone for advanced stomach cancer. The trial involved 885 patients who hadn't received previous treatment for their advanced cancer. Research…
Matched conditions: GASTROESOPHAGEAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists hunt for hidden cancer clues in Patients' surgical drain fluid
Knowledge-focused CompletedThis study aimed to find biological markers that could help predict which stomach or esophageal cancer patients might respond well to immunotherapy. Researchers collected fluid from surgical drains and blood samples from 10 patients who had cancer-removal surgery. They analyzed t…
Matched conditions: GASTROESOPHAGEAL CANCER
Sponsor: Inova Health Care Services • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC